Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. 1996

C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1876, USA.

In the present study, we have determined the kinetics of constitutive expression of a panel of cytokines [interleukin (IL) 2, IL-4, IL-6, IL-10, interferon gamma (IFN-gamma), and tumor necrosis factor alpha (TNF-alpha)] in sequential peripheral blood mononuclear cell samples from nine individuals with primary human immunodeficiency virus infection. Expression of IL-2 and IL-4 was barely detected in peripheral blood mononuclear cells. However, substantial levels of IL-2 expression were found in mononuclear cells isolated from lymph node. Expression of IL-6 was detected in only three of nine patients, and IL-6 expression was observed when transition from the acute to the chronic phase had already occurred. Expression of IL-10 and TNF-alpha was consistently observed in all patients tested, and levels of both cytokines were either stable or progressively increased over time. Similar to IL-10 and TNF-alpha, IFN-gamma expression was detected in all patients; however, in five of nine patients, IFN-gamma expression peaked very early during primary infection. The early peak in IFN-gamma expression coincided with oligoclonal expansions of CD8+ T cells in five of six patients, and CD8+ T cells mostly accounted for the expression of this cytokine. These results indicate that high levels of expression of proinflammatory cytokines are associated with primary infection and that the cytokine response during this phase of infection is strongly influenced by oligoclonal expansions of CD8+ T cells.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
June 2005, Current HIV/AIDS reports,
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
April 1993, Journal of virology,
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
July 1993, Proceedings of the National Academy of Sciences of the United States of America,
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
January 1995, Annales de dermatologie et de venereologie,
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
March 2008, Journal of virology,
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
November 1999, Obstetrics and gynecology,
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
December 1993, The Journal of infectious diseases,
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
January 2016, Voprosy virusologii,
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
November 2002, Internal medicine (Tokyo, Japan),
C Graziosi, and K R Gantt, and M Vaccarezza, and J F Demarest, and M Daucher, and M S Saag, and G M Shaw, and T C Quinn, and O J Cohen, and C C Welbon, and G Pantaleo, and A S Fauci
August 1994, The Journal of infectious diseases,
Copied contents to your clipboard!